The ERK1/2 pathway modulates nuclear PTEN-mediated cell cycle arrest by cyclin D1 transcriptional regulation

Human Molecular Genetics

Volumn 15, Issue 17, 2006, Pages 2553-2559

  Chung, Ji Hyun ^a   Ostrowski, Michael C ^a,b   Romigh, Todd ^c   Minaguchi, Takeo ^c   Waite, Kristin A ^c   Eng, Charis ^a,b,c,d,e  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d TAUSSIG CANCER INSTITUTE   (United States)

^e CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; MITOGEN ACTIVATED PROTEIN KINASE 1; MUTANT PROTEIN; NUCLEAR PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL CULTURE; CELL COMPARTMENTALIZATION; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL NUCLEUS; CONTROLLED STUDY; DOWN REGULATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; VECTOR CONTROL; WILD TYPE;

CELL CYCLE; CELL LINE, TUMOR; CELL NUCLEUS; CYCLIN D1; DOWN-REGULATION; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; NUCLEAR LOCALIZATION SIGNALS; PHOSPHORYLATION; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION; SUPPRESSION, GENETIC; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 33747876794     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddl177     Document Type: Article

References (30)

1. Eng, C. (2003) PTEN: One gene, many syndromes. Hum. Mutat., 22, 183-198.
2. Pilarski, R. and Eng, C. (2004) Will the real Cowden syndrome please stand up (again). Expanding mutation and clinical spectra of the PTEN hamartoma tumour syndrom. J. Med. Genet., 41, 323-326.
3. Waite, K.A. and Eng, C. (2002) Protean PTEN: Form and function. Am. J. Hum. Genet., 70, B29-B44.
4. Wu, H., Goel, V. and Haluska, F.G. (2003) PTEN signaling pathways in melanoma. Oncogene, 22, 3113-3122.
5. Chung, J.H. and Eng, C. (2005) Nuclear-cytoplasmic partitioning of phosphatase and tensin homologue deleted on chromosome 10 (PTEN) differentially regulates the cell cycle and apoptosis. Cancer Res., 65, 8096-8100.
6. Lukas, J., Bartkova, J., Welcker, M., Petersen, O.W., Peters, G., Strauss, M. and Bartek, J. (1995) Cyclin D2 is a moderately oscillating nucleoprotein required for G1 phase progression in specific cell types. Oncogene, 10, 2125-2134.
7. Bartkova., J., Lukas, J., Strauss, M. and Bartek, J. (1995) Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis. Oncogene, 10, 775-778.
8. Diehl, J.A., Cheng, M., Roussel, M.F. and Sherr, C.J. (1998) Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev., 12, 3499-3511.
9. Gingras, A.C., Kennedy, S.G., O'Leary, M.A., Sonenberg, N. and Hay, N. (1998) 4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway. Genes Dev., 12, 502-513.
10. Wada, T. and Penninger, J.M. (2004) Mitogen-activated protein kinases in apoptosis regulation. Oncogene, 23, 2838-2849.
11. Lavoie, J.N., L'Allemain, G., Brunet, A., Muller, R. and Pouyssegur, J. (1996) Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J. Biol. Chem., 271, 20608-20616.
12. Davis, M.W., Buechter, D.D. and Schimmel, P. (1994) Functional dissection of a predicted class-defining motif in a class II tRNA synthetase of unknown structure. Biochemistry, 33, 9904-9911.
13. Sherr, C.J. (2004) Principles of tumor suppression. Cell, 116, 235-246.
14. Sherr, C.J. (2000) The Pezcoller lecture: Cancer cell cycles revisited. Cancer Res., 60, 3689-3695.
15. Ewen, M.E., Sluss, H.K., Sherr, C.J., Matsushime, H., Kato, J. and Livingston, D.M. (1993) Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell, 73, 487-497.
16. Brehm, A., Miska, E.A., McCance, D.J., Reid, J.L., Bannister, A.J. and Kouzarides, T. (1998) Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature, 391, 597-601.
17. Ginn-Pease, M.E. and Eng, C. (2003) Increased nuclear phosphatase and tensin homologue deleted on chromosome 10 is associated with G0G1 in MCF-7 cells. Cancer Res., 63, 282-286.
18. Chung, J.H., Ginn-Pease, M.E. and Eng, C. (2005) Phosphatase and tensin bomologue deleted on chromosome 10 (PTEN) has nuclear localization signal-like sequences for nuclear import mediated by major vault protein. Cancer Res., 65, 4108-4116.
19. Liu, J.L., Sheng, X., Hortobagyi, Z.K, Mao, Z., Gallick, G.E. and Yung, W.K. (2005) Nuclear PTEN-mediated growth suppression is independent of Akt down-regulation. Mol. Cell. Biol., 25, 6211-6224.
20. Luo, H., Zhang, J., Dastvan, F., Yanagawa, B., Reidy, M.A., Zhang, H.M., Yang, D., Wilson, J.E. and McManus, B.M. (2003) Ubiquitin-dependent proteolysis of cyclin D1 is associated with coxsackievirus-induced cell growth arrest. J. Virol., 77, 1-9.
21. Musgrove, E.A., Hamilton, J.A., Lee, C.S., Sweeney, K.J., Watts, C.K. and Sutherland, R.L. (1993) Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression. Mol. Cell. Biol., 13, 3577-3587.
22. Weng, L.P., Brown, J.L., Baker, K.M., Ostrowski, M.C. and Eng, C. (2002) PTEN blocks insulin-mediated Ets-2 phosphorylation through MAP kinase, independent of the phosphoinositide-3-kinase pathway. Hum. Mol. Genet., 11, 1687-1696.
23. Radu, A., Neubauer, V., Akagi, T., Hanafusa, H. and Georgescu, M.M. (2003) PTEN induces cell cycle arrest by decreasing the level and nuclear localization of cyclin D1. Mol. Cell. Biol., 23, 6139-6149.
24. Bai, J., Nakamura, H., Ueda, S., Kwon, Y.W., Tanaka, T., Ban, S. and Yodoi, J. (2004) Proteasome-dependent degradation of cyclin D1 in 1-methyl-4-phenylpyridinium ion (MPP+)-induced cell cycle arrest. J. Biol. Chem., 279, 38710-38714.
25. Whitmarsh, A.J., Shore, P., Sharrocks, A.D. and Davis, R.J. (1995) Integration of MAP kinase signal transduction pathways at the serum response element. Science, 269, 403-407.
26. Terada, Y., Inoshita, S., Nakashima, O., Kuwahara, M., Sasaki, S. and Marumo, F. (1999) Regulation of cyclin D1 expression and cell cycle progression by mitogen-activated protein kinase cascade. Kidney Int., 56, 1258-1261.
27. Lewis, J.S., Thomas, T.J., Pestell, R.G., Albanese, C., Gallo, M.A. and Thomas, T. (2005) Differential effects of 16alpha-hydroxyestrone and 2-methoxyestradiol on cyclin D1 involving the transcription factor ATF-2 in MCF-7 breast cancer cells. J. Mol. Endocrinol., 34, 91-105.
28. Albanese, C., Johnson, J., Watanabe, G., Eklund, N., Vu, D., Arnold, A. and Pestell, R.G. (1995) Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J. Biol. Chem., 270, 23589-23597.
29. Herber, B., Truss, M., Beato, M. and Muller, R. (1994) Inducible regulatory elements in the human cyclin D1 promoter. Oncogene, 9, 1295-1304.
30. Weng, L.-P., Smith, W.M., Dahia, P.L.M., Ziebold, U., Gil, E., Lees, J.A. and Eng, C. (1999) PTEN suppresses breast cancer cell growth by phosphatase function-dependent G1 arrest followed by apoptosis. Cancer Res., 59, 5808-5814.